New to Meducation?
Sign up
Already signed up? Log In

Category

Preview
0
3

A Patient With BRAF-Positive Metastatic Melanoma CME

This activity is intended for oncologists, dermatologists, and other healthcare professionals who treat patients with melanoma.  
medscape.org
about 4 years ago
Preview
0
0

A Patient Experiencing Immune-Related Adverse Events CME

This activity is intended for oncologists, dermatologists, and other healthcare professionals who treat patients with melanoma.  
medscape.org
about 4 years ago
Preview
0
0

Incorporating Patient-Centered Management in Metastatic Melanoma CME

: Dr Geoff Gibney provides 2 cases to examine some of the decision-making surrounding treating patients with metastatic melanoma.  
medscape.org
about 4 years ago
Preview
0
0

Dupuytren's Contractures Associated With Vemurafenib

Was treatment with the BRAF inhibitor vemurafenib responsible for the development of Dupuytren's contracture in this patient with metastatic melanoma?  
medscape.com
about 4 years ago
Preview
0
0

Adjuvant Treatment, Peptide Vaccine Do Not Improve Melanoma Survival

Adjuvant treatment with granulocyte-macrophage colony-stimulating factor (GM-CSF) and peptide vaccine does not improve survival in patients with high-risk melanoma, researchers report.  
medscape.com
about 4 years ago
Preview
0
12

Melanoma skin cancer guidelines for NHS updated - BBC News

New guidelines for diagnosing and treating melanoma skin cancers have been issued to the NHS in England.  
bbc.co.uk
over 4 years ago
Preview
0
3

Lymph node biopsy followed by lymph node dissection for localised skin cancer | Cochrane

Melanoma arises from the uncontrollable growth of cells in the skin that produce the pigment melanin; it is the leading cause of skin cancer-associated mortality. In invasive melanoma, the tumour has infiltrated into the dermis (a deep layer in the skin).  
cochrane.org
over 4 years ago
Nci 150420 metastatic melanoma 800x600
0
10

One in Five Melanomas Undetectable After Immune Drug Combo

Combining nivolumab and ipilimumab also resulted in nearly a quarter of patients having their advanced melanoma become undetectable. Experts are excited.  
medscape.com
over 4 years ago
Preview
0
8

Paradigm Shift: Anti-PD-1 Keytruda Tops Yervoy for Melanoma

The newer drug, pembrolizumab, is a better first-line therapy than ipilimumab for advanced melanoma.  
medscape.com
over 4 years ago
Preview
0
4

Deadly skin cancer much more common in today's seniors

British people aged 65 and over are seven times more likely to develop malignant melanoma than seniors from 4 decades ago, partly due to the rise of cheap all-inclusive holidays.  
medicalnewstoday.com
over 4 years ago
Preview
0
2

Personalized vaccine shows promise against melanoma recurrence

Encouraging results from a 'first-in-people' trial have led the FDA to approve the phase 1 clinical study of an experimental, personalized anticancer vaccine.  
medicalnewstoday.com
over 4 years ago
Preview
0
3

Rutgers Cancer Institute of New Jersey research shows gene removal may aid melanoma treatment

Nearly 10,000 deaths from melanoma - the deadliest of all skin cancers - occurred in the U.S. last year, according to the National Cancer Institute.  
medicalnewstoday.com
over 4 years ago
Preview
0
8

UCLA researchers combine benefits of immunotherapy and cancer-targeted treatment in triple combo drug for melanoma

Results of a new study by UCLA researchers has found that a new triple combination drug therapy shows promising signs of more effectively controlling advanced melanoma than previous BRAF + MEK...  
medicalnewstoday.com
over 4 years ago
Preview
0
9

Macrophages may play critical role in melanoma resistance to BRAF inhibitors

With targeted therapies no longer viewed as a 'magic bullet' for cancer treatment, this study suggests that macrophages could be a new therapeutic target for patients with...  
medicalnewstoday.com
over 4 years ago
Preview
0
8

Gene mutations may predict melanoma response to immunotherapies

Melanoma patients whose tumors test positive for mutations in the NRAS gene were more likely to benefit from new immunotherapy drugs, according to a new study led by Vanderbilt-Ingram Cancer...  
medicalnewstoday.com
over 4 years ago
Preview
0
2

Nodal alone does not produce anti-cancer effects

Metastatic melanoma is the leading cause of skin cancer deaths in the United States; once melanoma has spread (metastasized), life expectancy for patients can be dramatically shortened.  
medicalnewstoday.com
over 4 years ago
Preview
0
5

KEYTRUDA (pembrolizumab) is first medicine to be made available to patients through U.K. Early Access to Medicines Scheme (EAMS) for advanced melanoma

Merck, known as MSD outside the United States and Canada, has announced that the company's anti-PD-1 therapy, pembrolizumab, which is marketed in the U.S.  
medicalnewstoday.com
over 4 years ago
Preview
0
1

Radiation plus immunotherapy combo revs up immune system to better attack melanoma, Penn study suggests

Radiation plus ipilimumab shrank tumors in some patients, but preclinical data suggests adding second immunotherapy will elicit response in resistant patientsTreating metastatic...  
medicalnewstoday.com
over 4 years ago
Preview
0
15

Myriad publishes myPath Melanoma pivotal validation study

Myriad Genetics, Inc. has announced the Journal of Cutaneous Pathology published data from a pivotal clinical validation study that showed the myPath Melanoma test is highly effective...  
medicalnewstoday.com
over 4 years ago